DLB vs RGLD
Dolby Laboratories, Inc. and Royal Gold, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | DLB | RGLD |
|---|---|---|
| Revenue | $1.3B | $1.0B |
| Net income | $255.0M | $466.3M |
| Gross margin | 88.1% | 69.3% |
| Net margin | 18.9% | 45.2% |
| Return on equity | 10.0% | 9.1% |
| Diluted EPS | — | $6.69 |
| Dividend / share | $1.32 | $1.82 |
| Payout ratio | 49.6% | 25.4% |
| Free cash flow | $435.9M | — |
| Equity | $2.6B | $7.2B |
| Net debt / equity | — | 0.09× |
| Current ratio | 3.17× | 3.12× |
| Revenue CAGR 5y | 3.0% | 10.8% |
| Profit CAGR 5y | 2.0% | 9.0% |
DLB bills 1.3× the revenue of RGLD, and RGLD keeps more of each dollar of revenue as profit (45.2% against 18.9%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | DLB | RGLD |
|---|---|---|
| FY2025 | $1.3B | $1.0B |
| FY2024 | $1.3B | $719.4M |
| FY2023 | $1.3B | $605.7M |
| FY2022 | $1.3B | $603.2M |
| FY2021 | $1.3B | $653.6M |
| FY2020 | $1.2B | $615.9M |
| FY2019 | $1.2B | $498.8M |
| FY2018 | $1.1B | $423.1M |
| FY2017 | $1.1B | $459.0M |
| FY2016 | $1.0B | $440.8M |
Net income by year
Bottom line
| Fiscal year | DLB | RGLD |
|---|---|---|
| FY2025 | $255.0M | $466.3M |
| FY2024 | $261.8M | $332.0M |
| FY2023 | $200.7M | $239.4M |
| FY2022 | $184.1M | $239.0M |
| FY2021 | $310.2M | $274.0M |
| FY2020 | $231.4M | $302.5M |
| FY2019 | $255.2M | $199.3M |
| FY2018 | $41.7M | $93.8M |
| FY2017 | $206.5M | $-113.1M |
| FY2016 | $185.9M | $101.5M |
Advertisement
AdSense · Rectangle 336×280
More in this industry